The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.
Open accessAbstract
Background & aims Nonalcoholic fatty liver disease is associated with insulin resistance and diabetes. The purpose of this study was to determine the relationship between intrahepatic triglyceride (IHTG) content and insulin action in liver (suppression of glucose production), skeletal muscle (stimulation of glucose uptake), and adipose tissue (suppression of lipolysis) in nondiabetic obese subjects.Methods A euglycemic-hyperinsulinemic clamp procedure and stable isotopically labeled tracer infusions were used to assess insulin action, and magnetic resonance spectroscopy was used to determine IHTG content, in 42 nondiabetic obese subjects (body mass index, 36 +/- 4 kg/m(2)) who had a wide range of IHTG content (1%-46%).Results Hepatic insulin sensitivity, assessed as a function of glucose production rate and plasma insulin concentration, was inversely correlated with IHTG content (r = -0.599; P < .001). The ability of insulin to suppress fatty acid release from adipose tissue and to stimulate glucose uptake by skeletal muscle were also inversely correlated with IHTG content (adipose tissue: r = -0.590, P < .001; skeletal muscle: r = -0.656, P < .001). Multivariate linear regression analyses found that IHTG content was the best predictor of insulin action in liver, skeletal muscle, and adipose tissue, independent of body mass index and percent body fat, and accounted for 34%, 42%, and 44% of the variability in these tissues, respectively (P < .001 for each model).Conclusions These results show that progressive increases in IHTG content are associated with progressive impairment of insulin action in liver, skeletal muscle, and adipose tissue in nondiabetic obese subjects. Therefore, nonalcoholic fatty liver disease should be considered part of a multiorgan system derangement in insulin sensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, hepatic lipid accumulation is also a robust predictor of not only hepatic, but also muscle and adipose insulin sensitivity [better than intraabdominal fat, body mass index (BMI), or other obesity measures] (217, 218).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [218]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
The Michigan Alcoholism Screening Test: The Quest for a New Diagnostic Instrument
Selzer, M. L. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.127.12.1653 · Cited by 3,431
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,728
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,658
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 592
London, A., Richter, M. M., Sjøberg, K. A., Albrechtsen, N. J. W., Považan, M., Drici, L., Schaufuss, A., Madsen, L., Øyen, J., Madsbad, S., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.06.006 · Cited by 26
Salidroside in the Treatment of NAFLD/NASH
Qu, B., Liu, X., Liang, Y., Zheng, K., Zhang, C., & Lu, L. (2022) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200401 · Cited by 26
Dongiovanni, P., & Valenti, L. V. C. (2013) · PPAR Research · doi:10.1155/2013/452061 · Cited by 27
At the Crossroads of Health and Disease: Consequences of Fat in the Liver
Dukewich, M., Yuan, L., & Terrault, N. A. (2025) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022724-105515 · Cited by 35
Coccia, F., Testa, M., Guarisco, G., Cristofano, C. D., Silecchia, G., Leonetti, F., Gastaldelli, A., & Capoccia, D. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.08.001 · Cited by 25
Yoshino, S., Iwasaki, Y., Matsumoto, S., Satoh, T., Ozawa, A., Yamada, E., Kakizaki, S., Trejo, J. A. O., Uchiyama, Y., Yamada, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70689-5 · Cited by 25
Jovanović, G. K., Mrakovčić-Šutić, I., Žeželj, S. P., Horvat, I. B., Šuša, L., Rahelić, D., & Majanović, S. K. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/6649142 · Cited by 28
Posadas‐Sánchez, R., Ocampo-Arcos, W. A., López-Uribe, Á. R., Posadas‐Romero, C., Villarreal-Molina, M. T., León, E. Á., Pérez‐Hernández, N., Rodrı́guez-Pérez, J. M., Cardoso-Saldaña, G. C., Medina-Urrutia, A. X., et al. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.12.010 · Cited by 25
Fujikawa, Y., Tominaga, K., Fujii, H., Machida, H., Okazaki, H., Yamagami, H., Tanigawa, T., Watanabe, K., Watanabe, T., Fujiwara, Y., et al. (2012) · Digestion · doi:10.1159/000341418 · Cited by 25
Clinical physiology of NAFLD: a critical overview of pathogenesis and treatment
Lonardo, A., Caldwell, S. H., & Loria, P. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.5 · Cited by 25
Cheong, H., Lee, S. S., Lee, J. S., Kim, J., Kim, S. W., & Lee, W. J. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24674 · Cited by 25
Fetuin A is a Predictor of Liver Fat in Preoperative Patients with Nonalcoholic Fatty Liver Disease
von Loeffelholz, C., Horn, P., Birkenfeld, A. L., Claus, R. A., Metzing, U. B., Döcke, S., Jahreis, G., Heller, R., Hoppe, S., Stockmann, M., et al. (2016) · Journal of Investigative Surgery · doi:10.3109/08941939.2016.1149640 · Cited by 25
Characteristics of hepatic insulin‐sensitive nonalcoholic fatty liver disease
Shigiyama, F., Kumashiro, N., Furukawa, Y., Funayama, T., Takeno, K., Wakui, N., Ikehara, T., Nagai, H., Taka, H., Fujimura, T., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1077 · Cited by 25
Dai-Zong-Fang, A Traditional Chinese Herbal Formula, Ameliorates Insulin Resistance in db/db Mice
Zhu, L., Zhu, X., Sun, G., Meng, X., Wang, M., Cui, H., Wang, J., Zhai, Y., Yang, K., Tang, Y., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00224 · Cited by 25
Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance
Cree‐Green, M., Wiromrat, P., Stuppy, J. J., Thurston, J. E., Bergman, B. C., Baumgartner, A., Bacon, S. D., Scherzinger, A. L., Pyle, L. L., & Nadeau, K. J. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00258.2018 · Cited by 25
Tip60-mediated Rheb acetylation links palmitic acid with mTORC1 activation and insulin resistance
Zhao, Z., Chen, Q., Xiang, X., Dai, W., Fang, W., Cui, K., Li, B., Liu, Q., Liu, Y., Shen, Y.-N., et al. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202309090 · Cited by 24
Mechanisms coupling lipid droplets to MASLD pathophysiology
Reid, M. V., Fredrickson, G., & Mashek, D. G. (2024) · Hepatology · doi:10.1097/hep.0000000000001141 · Cited by 26
Beyond BMI: Exploring obesity trends in the south Asian region
Riaz, M., & Lodhi, S. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2024.100156 · Cited by 24
Drummen, M., Dorenbos, E., Vreugdenhil, A. C. E., Raben, A., Fogelholm, M., Westerterp‐Plantenga, M. S., & Adam, T. C. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00162.2018 · Cited by 26
Pourhassan, M., Glüer, C.-C., Pick, P., Tigges, W. P., & Müller, M. J. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.189 · Cited by 26
Muscle Attenuation Is Associated With Newly Developed Hypertension in Men of African Ancestry
Zhao, Q., Zmuda, J. M., Kuipers, A. L., Bunker, C. H., Patrick, A. L., Youk, A. O., & Miljkovic, I. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08415 · Cited by 24
Abdollahi, A., Narayanan, S. K., Frankovich, A., Lai, Y., Zhang, Y., & Henderson, G. C. (2023) · Nutrients · doi:10.3390/nu15092060 · Cited by 24
Hepatic function and the cardiometabolic syndrome
Wiernsperger, N. F. (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s51145 · Cited by 26
Molecular imaging of diabetes and diabetic complications: Beyond pancreatic β-cell targeting
Yang, J., Zhang, L. J., Wang, F., Hong, T., & Liu, Z. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.11.007 · Cited by 25
Metabolic disorders associated with chronic hepatitis C: impact of genotype and ethnicity
Sersté, T., Nkuize, M., Moucari, R., Gossum, M. V., Reynders, M., Scheen, R., Vertongen, F., Buset, M., Mulkay, J., & Marcellin, P. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02291.x · Cited by 23
Sherry, A. P., Willis, S. A., Yates, T. E., Johnson, W., Razieh, C., Sargeant, J. A., Malaikah, S., Stensel, D. J., Aithal, G. P., & King, J. A. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100622 · Cited by 24
White, U. A., Beyl, R. A., & Ravussin, É. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01150-y · Cited by 24
Torres, L., Schuch, A., Longo, L., Valentini, B. B., Galvão, G. S., Luchese, E., Pinzon, C., Bartels, R., & Álvares‐da‐Silva, M. R. (2022) · Annals of Hepatology · doi:10.1016/j.aohep.2022.100774 · Cited by 21
Cornford, A. S., Hinko, A., Nelson, R. K., Barkan, A. L., & Horowitz, J. F. (2012) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0266 · Cited by 21
Reeds, D. N., Pietka, T., Yarasheski, K. E., Cade, W. T., Patterson, B. W., Okunade, A. L., Abumrad, N. A., & Klein, S. (2017) · Obesity · doi:10.1002/oby.21793 · Cited by 21
Self-citationMangia, A., & Andriulli, A. (2010) · Hepatology · doi:10.1002/hep.23742 · Cited by 21
Metabolic-Associated Fatty Liver Disease and Insulin Resistance: A Review of Complex Interlinks
Barber, T. M., Kabisch, S., Pfeiffer, A. F. H., & Weickert, M. O. (2023) · Metabolites · doi:10.3390/metabo13060757 · Cited by 22
Hoenig, M. E. (2014) · Veterinary Sciences · doi:10.3390/vetsci1020121 · Cited by 24
Manti, S., Romano, C., Chirico, V., Filippelli, M., Cuppari, C., Loddo, I., Salpietro, C. D., & Arrigo, T. (2014) · Hepatitis Monthly · doi:10.5812/hepatmon.17641 · Cited by 22
Diabetes prevalence in NZO females depends on estrogen action on liver fat content
Lubura, M., Hesse, D., Kraemer, M., Hallahan, N., Schupp, M., von Löffelholz, C., Kriebel, J., Rudovich, N. N., Pfeiffer, A. F. H., John, C., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00338.2015 · Cited by 22
Chang, T.-Y., Wu, C., Chang, C., Lee, F., Wang, B.-W., Doong, J.-Y., Lin, Y., Kuo, C.-S., & Huang, R.-F. S. (2022) · Nutrients · doi:10.3390/nu14020261 · Cited by 20
Meal timing effects on insulin sensitivity and intrahepatic triglycerides during weight loss
Versteeg, R. I., Ackermans, M. T., Nederveen, A. J., Fliers, E., Serlie, M. J. M., & la Fleur, S. E. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.199 · Cited by 20
Roflumilast Suppresses Adipogenic Differentiation via AMPK Mediated Pathway
Xu, W., Zhang, J., & Xiao, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.662451 · Cited by 19
Metabolic-Associated Fatty Liver Disease and Sarcopenia
Bali, T., Chrysavgis, L., & Cholongitas, Ε. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2023.02.004 · Cited by 21
McLaughlin, T., Yee, G., Glassford, A. J., Lamendola, C. A., & Reaven, G. M. (2011) · Metabolism · doi:10.1016/j.metabol.2011.05.008 · Cited by 19
Vessby, B., Åhrén, B., Warensjö, E., & Lindgärde, F. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.07.011 · Cited by 19
Baktır, A. O., Şarlı, B., Altekin, R. E., Karaman, A., Arınç, H., Sağlam, H., Doğan, Y., Erden, A., & Karaman, H. (2014) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2014.5212 · Cited by 19
Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes
Barchetta, I., Angelico, F., Ben, M. D., Martino, M. D., Cimini, F. A., Bertoccini, L., Polimeni, L., Catalano, C., Fraioli, A., Vescovo, R. D., et al. (2016) · Clinical Science · doi:10.1042/cs20160348 · Cited by 19
Fredrikson, D. H., Boyda, H. N., Tse, L., Whitney, Z., Pattison, M. A., Ott, F. J., Hansen, L., & Barr, A. M. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00105 · Cited by 19
Tuazon, M. A., McConnell, T. R., Wilson, G. J., Anthony, T. G., & Henderson, G. C. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00440.2014 · Cited by 19
Novel circulating biomarkers for non‐alcoholic fatty liver disease: A systematic review
Sahebkar, A., Sancho, E., Abelló, D., Camps, J., & Joven, J. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25779 · Cited by 20
Incidence of type 2 diabetes in familial combined hyperlipidemia
Brouwers, M. C. G. J., Graaf, J. D., Simons, N., Meex, S. J. R., ten Doeschate, S., van Heertum, S., Heidemann, B. E., Luijten, J., de Boer, D., Schaper, N. C., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001107 · Cited by 19
Reed, R. M., Nevitt, S. J., Kemp, G. J., Cuthbertson, D. J., Whyte, M., & Goff, L. M. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01797-5 · Cited by 17
Discovery of spirocyclic-diamine inhibitors of mammalian acetyl CoA-carboxylase
Kung, D. W., Griffith, D. A., Esler, W. P., Vajdos, F. F., Mathiowetz, A. M., Doran, S. D., Amor, P. A., Bagley, S. W., Banks, T., Cabral, S., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.035 · Cited by 17
Nonalcoholic steatohepatitis and insulin resistance in children
Arata, M. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i6.917 · Cited by 18
Gadéa, É., Thivat, É., Paulon, R., Mishellany, F., Gimbergues, P., Capel, F., Mosoni, L., Merlin, C., Lombès, M., Morio, B., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2829 · Cited by 18
Quantum coherence spectroscopy to measure dietary fat retention in the liver
Lindeboom, L., de Graaf, R. A., Nabuurs, C. I. H. C., van Ewijk, P. A., Hesselink, M. K. C., Wildberger, J. E., Schrauwen, P., & Schrauwen‐Hinderling, V. B. (2016) · JCI Insight · doi:10.1172/jci.insight.84671 · Cited by 18
Rämö, J. T., Kaye, S. M., Jukarainen, S., Bogl, L. H., Hakkarainen, A., Lundbom, J., Lundbom, N. M. I., Rissanen, A., Kaprio, J. A., Matikainen, N., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3512 · Cited by 20
Lindroos, M. M., Borra, R., Mononen, N., Lehtimäki, T. J., Virtanen, K. A., Saunavaara, V., Guiducci, L., Iozzo, P., Majamaa, K., & Nuutila, P. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9338-0 · Cited by 18
Zhang, Y., Guo, Y., Li, X., Ruan, J., Wang, T., Li, J., Han, L., Yu, H., & Wang, T. (2016) · Tetrahedron · doi:10.1016/j.tet.2016.09.034 · Cited by 18
Stable isotope-based flux studies in nonalcoholic fatty liver disease
McCullough, A. J., Previs, S. F., & Kasumov, T. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.008 · Cited by 18
Adipose Tissue in Health and Disease
Leff, T., & Granneman, J. G. (2010) · Wiley eBooks · doi:10.1002/9783527629527 · Cited by 19
Arias-Hernández, D., García‐Jiménez, S., Domínguez-Roldan, R., Mejía, C. M., Báez‐Saldaña, A., Hallal-Calleros, C., & Flores-Pérez, I. (2020) · Pathogens · doi:10.3390/pathogens9110861 · Cited by 17
Adiponectin and the Control of Metabolic Dysfunction: Is Exercise the Magic Bullet?
Otu, L. I., & Otu, A. A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.651732 · Cited by 19
Koay, Y. C., Coster, A. C. F., Chen, D. L., Milner, B., Batarseh, A. M., O’Sullivan, J., Greenfield, J. R., & Samocha‐Bonet, D. (2022) · Metabolites · doi:10.3390/metabo12121272 · Cited by 17
Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance
Zeng, Q., Liu, C., Ampuero, J., Wu, D., Jiang, W., Zhou, L., Li, H., Bai, L., Romero‐Gómez, M., & Tang, H. (2023) · RNA Biology · doi:10.1080/15476286.2023.2290769 · Cited by 18
Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk
Du, T., Yu, X., Yuan, G., Zhang, J., & Sun, X. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0306-0 · Cited by 17
Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes
Bril, F., McPhaul, M. J., Kalavalapalli, S., Lomonaco, R., Barb, D., Gray, M. E., Shiffman, D., Rowland, C. M., & Cusi, K. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab417 · Cited by 17
Fang, H., Cao, Y., Zhang, J., Wang, X., Li, M., Hong, Z., Wu, Z., & Fang, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1146276 · Cited by 16
Intrahepatic lipid content is linked to insulin resistance in obese subjects
Sada, Y., Katabami, T., Asai, S., Sato, T., Furukawa, K., Ishii, S., Kato, H., KOBAYASHI, H., Kondo, A., Ohta, A., et al. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2010.12.007 · Cited by 16
Effect of Pregnancy for Females Born Small on Later Life Metabolic Disease Risk
Tran, M., Gallo, L. A., Wadley, G. D., Jefferies, A. J., Moritz, K. M., & Wlodek, M. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045188 · Cited by 16
Grujić-Milanović, J. D., Miloradović, Z., Mihailovic‐Stanojevic, N., Banjac, V. V., Vidosavljević, S., Ivanov, M., Karanović, D., Vajić, U.-J., & Jovović, D. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111691 · Cited by 16
Yin, C., Jin, Y., Liu, Y., Wang, L., & Xiao, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214606 · Cited by 17
Tsamos, G., Vasdeki, D., Koufakis, T., Michou, V., Makedou, K., & Tzimagiorgis, G. (2023) · Metabolites · doi:10.3390/metabo13040517 · Cited by 16
Zhang, J., Wang, S., Wang, J., Liu, W., Gong, H., Zhang, Z., Lyu, B., & Yu, H. (2023) · Foods · doi:10.3390/foods12102081 · Cited by 18
Oh, E., Cho, N., Kang, H., Kim, S. H., Park, H. K., & Kwon, S. H. (2023) · PLoS ONE · doi:10.1371/journal.pone.0296073 · Cited by 15
Reytor-González, C., Annunziata, G., Campuzano-Donoso, M., Morales-López, T., Basantes-Tituaña, C., Fascì-Spurio, F., Verde, L., Muscogiuri, G., Barrea, L., Frías-Toral, E., et al. (2025) · Minerva Endocrinology · doi:10.23736/s2724-6507.24.04314-8 · Cited by 15
Non-alcoholic fatty liver disease and cardiovascular disease
Santos, R. D., & Agewall, S. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.07.018 · Cited by 15
World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease
Bloomgarden, Z. T. (2011) · Diabetes Care · doi:10.2337/dc11-1306 · Cited by 15
Sopher, A. B., Gerken, A. T., Blaner, W. S., Root, J. M., McMahon, D. J., & Oberfield, S. E. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.01.111 · Cited by 15
Copaci, I., Lupescu, I. G., Caceaune, E., Chiriac, G., & Ismail, G. (2015) · Romanian Journal of Internal Medicine · doi:10.1515/rjim-2015-0008 · Cited by 15
Gómez-Ruiz, A., Milagro, F. I., Campión, J., Martínez, J. A., & de Miguel, C. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-55 · Cited by 15
Seko, Y., Yamaguchi, K., Tochiki, N., Yano, K., Takahashi, A., Okishio, S., Kataoka, S., Okuda, K., Umemura, A., Moriguchi, M., et al. (2021) · Genes · doi:10.3390/genes12050628 · Cited by 15
Carabrone Attenuates Metabolic Dysfunction–Associated Steatohepatitis by Targeting STAT3 in Mice
Pan, A., Jin, J., Wu, Y., Zhang, Q., Chen, H., Hu, Y., Xiao, W., Shi, A., Yang, Y., Jiang, L., et al. (2025) · MedComm · doi:10.1002/mco2.70145 · Cited by 14
Zulkifli, B., Fakri, F., Odigie, J., Nnabuife, L. C., Isitua, C. C., & Chiari, W. (2023) · Narra X · doi:10.52225/narrax.v1i1.80 · Cited by 14
Kaume, L., Gilbert, W., Gadang, V., & Devareddy, L. (2011) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v1i5.130 · Cited by 14
Klein, S., & Romijn, J. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00036-8 · Cited by 14
Self-citationEstimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease
Shrestha, R., Sudhamshu, K. C., Thapa, P., Pokharel, A., Karki, N., & Jaishi, B. (2021) · Cureus · doi:10.7759/cureus.16414 · Cited by 14
COVID-19 and liver injury in individuals with obesity
Lempesis, I. G., Karlafti, E., Papalexis, P., Fotakopoulos, G., Tarantinos, K., Lekakis, V., Papadakos, S. P., Cholongitas, Ε., & Georgakopoulou, V. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i6.908 · Cited by 16
Park, S.-Y., Jin, B., Shin, J.-H., Adisakwattana, S., & Kwon, O. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.080 · Cited by 14
The synthetic rate of muscle triglyceride but not phospholipid is increased in obese rabbits
Zhang, X., Chinkes, D. L., Wu, Z., Herndon, D. N., & Wolfe, R. R. (2009) · Metabolism · doi:10.1016/j.metabol.2009.05.021 · Cited by 14
Bahadoran, Z., Mirmiran, P., Kashfi, K., & Ghasemi, A. (2024) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-024-01709-w · Cited by 13
Tiash, S., Patel, S. A., Russo, M., Suresh, A., Pang, B., Pai, Y.-L., Jia, W., Field, R. L., Pietka, T., Abumrad, N. A., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.02.008 · Cited by 13
Lundsgaard, A., Bojsen-Møller, K. N., & Kiens, B. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.08.005 · Cited by 14
Mellor, D. D., & Naumovski, N. (2016) · International Journal of Food Science & Technology · doi:10.1111/ijfs.13075 · Cited by 13
Schübel, R., Nonnenmacher, T., Sookthai, D., Maldonado, S. G., Sowah, S. A., von Stackelberg, O., Schlett, C. L., Grafetstätter, M., Nabers, D., Johnson, T., et al. (2019) · Nutrients · doi:10.3390/nu11030544 · Cited by 13
Thonusin, C., Pantiya, P., Kongkaew, A., Nawara, W., Arunsak, B., Sriwichaiin, S., Chattipakorn, N., & Chattipakorn, S. C. (2023) · Nutrients · doi:10.3390/nu15235004 · Cited by 12
Lindeboom, L., & de Graaf, R. A. (2017) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26740 · Cited by 12
Kakisaka, K., Sasaki, A., Umemura, A., Nikai, H., Suzuki, Y., Nishiya, M., Sugai, T., Nitta, H., & Takikawa, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-94937-4 · Cited by 11
Tricò, D., Galderisi, A., Name, M. A. V., Caprio, S., Samuels, S. L., Li, Z., Galuppo, B., Savoye, M., Mari, A., Feldstein, A. E., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14695 · Cited by 11
Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Giannopoulos, C., Tzima, I. G., Tentolouris, N., & Vasileiadis, I. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230216112032 · Cited by 12
Nonalcoholic Fatty Liver Disease
Dancygier, H. (2009) · Springer eBooks · doi:10.1007/978-3-642-04519-6_35 · Cited by 11
Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop
Peters, H. P. F., Schrauwen, P., Verhoef, P., Byrne, C. D., Mela, D. J., Pfeiffer, A. F. H., Risérus, U., Rosendaal, F. R., & Schrauwen‐Hinderling, V. B. (2017) · Journal of Nutritional Science · doi:10.1017/jns.2017.13 · Cited by 11
Malaikah, S., Willis, S. A., Henson, J. J., Sargeant, J. A., Yates, T. E., Thackray, A. E., Goltz, F. R., Roberts, M. J., Bodicoat, D. H., Aithal, G. P., et al. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01350-0 · Cited by 11
Effect of vinyl chloride exposure on cardiometabolic toxicity
Zelko, I. N., Taylor, B. S., Das, T. P., Watson, W. H., Sithu, I. D., Wahlang, B., Malovichko, M. V., Cave, M. C., & Srivastava, S. (2021) · Environmental Toxicology · doi:10.1002/tox.23394 · Cited by 9
Metadata
- Authors
- Korenblat, K. M., Fabbrini, E., Mohammed, B. S., & Klein, S.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Klein, Samuel
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 134
- Issue
- 5
- Pages
- 1369-1375
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC2629391
- OpenAlex
- W2071867050
- Semantic Scholar
- 583ea7ff89ae3ebd20b01708b92228e15c0f7b02
- Cited by
- 592
- References
- 41
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 31 · 2023: 40 · 2022: 36 · 2021: 32 · 2020: 21 · 2019: 27 · 2018: 32 · 2017: 32 · 2016: 32 · 2015: 32 · 2014: 36 · 2013: 38 · 2012: 44
- FWCI
- 30.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Funders
- National Institutes of Health (DK 37948, DK 56341, RR-00954, RR-00036)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- intrahepatic triglyceride, insulin resistance, non-alcoholic fatty liver disease, hepatic insulin sensitivity, skeletal muscle glucose uptake, adipose tissue lipolysis, glucose production, obesity
- MeSH terms
- Adipose Tissue, Adult, Energy Metabolism, Female, Humans, Insulin, Insulin Resistance, Liver, Magnetic Resonance Imaging, Male, Magnetic Resonance Spectroscopy, Obesity, Prognosis, Risk Factors, Triglycerides, Glucose Clamp Technique, Biomarkers, Absorptiometry, Photon, Body Mass Index, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review